Omicron News and Research

RSS

People encouraged to get first and second dose of Covid vaccine before offer ends

People who have not yet come forward for their first and/ or second dose of the Covid vaccine are being encouraged to get their jabs before the offer ends on Friday 30 June.

5 May 2023

Evaluating the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines

Researchers evaluated the effectiveness, in absolute and relative terms, of vaccines.

5 May 2023

Study finds COVID-19 vaccine effectiveness against Omicron rapidly wanes over time

In a recent study published in the JAMA Network Open, researchers performed a systematic review and meta-analysis using secondary data from 40 published studies reporting time-varying, population-level coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) estimates against laboratory-confirmed infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, Omicron or Delta, and symptomatic disease.

5 May 2023

Unlocking the puzzle: How ACE2 shapes macrophage responses in COVID-19

A new study investigates whether SARS-CoV-2 can enter and replicate in macrophages and whether ACE2 is involved in these mechanisms.

4 May 2023

Millions struggle: The hidden impact of post-COVID conditions on US adults

Researchers propose a model that could be used as a foundation for future research to determine long COVID prevalence.

4 May 2023

Study provides the most comprehensive characterization of global COVID-19 variant transitions

A team of researchers at Los Alamos National Laboratory recently published the most comprehensive study of global COVID-19 variant transitions, which showed significant diversity in variant spread around the globe related to vaccination rates, number of co-circulating variants and immunity from previous infection.

4 May 2023

Study suggests SARS-CoV-2 vaccination in pregnancy induces diverging maternal and infant cord antibody functions

Researchers explored the differences in infant and maternal cord antibody functions between SARS-CoV-2 infection and vaccination during pregnancy.

4 May 2023

Europeans' life satisfaction recovers to pre-pandemic levels despite COVID-19 impact, study finds

Research analyzes the impact of the COVID-19 pandemic on life satisfaction in Europe over three years. The study finds that while the pandemic had an adverse impact on life satisfaction, on average, satisfaction with life in the summer of 2022 is about the same as the pre-pandemic value in the autumn of 2019.

3 May 2023

Study examines the reinfection of SARS-CoV-2 variants in children

Researchers characterized the children with severe acute respiratory syndrome coronavirus 2 reinfection.

3 May 2023

Monovalent mRNA COVID-19 vaccines provide durable protection against critical outcomes

Study reports on the effectiveness of monovalent mRNA vaccination in preventing COVID-19-associated invasive mechanical ventilation and death. In other words, the study looks at how well the mRNA vaccine works in preventing severe illness and death from COVID-19.

2 May 2023

New technology can deliver gene therapy directly to the lung

Scientists at UMass Chan Medical School have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments for lung disease.

2 May 2023

Cats and COVID-19: measuring seroprevalence against SARS-CoV-2 in domestic cats

Researchers tested the seroprevalence against SARS-CoV-2 in pet cats in the U.K.

2 May 2023

Tracking SARS-CoV-2 Omicron variant XBB1.16

The World Health Organization recently named the SARS-CoV-2 Omicron variant XBB1.16 a variant of interest to encourage tracking of this genetic variant of the pandemic coronavirus.

28 Apr 2023

NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescent

Research reports the results of a phase 3 clinical trial evaluating the safety, immunogenicity, and efficacy of the NVX-CoV2373 vaccine in adolescents aged 12 to 17 years. The study found that the vaccine was safe, immunogenic, and efficacious in preventing COVID-19, including the Delta variant, in adolescents.

27 Apr 2023

Research uncovers antibodies that are still effective against new variants of SARS-CoV-2

An anonymous San Diego resident has become a fascinating example of how the human immune system fights SARS-CoV-2.

26 Apr 2023

The Wonder of DNA: Reflections from Dr. Francis Collins on the 20th Anniversary of the Human Genome Project

To highlight how far the field of genetics has come, we spoke with Dr. Francis Collins, the leader of the Human Genome Project about his incredible career in genetics.

25 Apr 2023

Study outlines protocols for safely shipping goods without starting SARS-CoV-2 outbreak

The virus that causes COVID-19 spreads through droplets and small particles, but contaminated surfaces of shipping materials may also contribute to outbreaks.

24 Apr 2023

What are the trends in severe outcomes among patients hospitalized with COVID-19 during the first 2 years of the COVID-19 pandemic?

Researchers documented surveillance across a network of 155 acute care hospitals in Canada between March 15, 2020, and May 28, 2022.

24 Apr 2023

Deciphering immunological imprinting in the context of COVID-19

In a recent article published in the journal Immunity, researchers explained the concept of immunological imprinting and its underlying principles. They also discussed its potential role in the context of coronavirus disease 2019 (COVID-19) vaccines.

24 Apr 2023

Novel self-amplifying RNA vaccine confers durable protection against COVID-19, reduces viral shedding in primate study

A self-amplifying replicon RNA vaccine against SARS-CoV-2 can elicit durable and protective immunity in pigtail macaques, even after neutralizing antibody responses have waned to undetectable levels.

23 Apr 2023

Omicron News and Research

People encouraged to get first and second dose of Covid vaccine before offer ends

Evaluating the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines

Study finds COVID-19 vaccine effectiveness against Omicron rapidly wanes over time

Unlocking the puzzle: How ACE2 shapes macrophage responses in COVID-19

Millions struggle: The hidden impact of post-COVID conditions on US adults

Study provides the most comprehensive characterization of global COVID-19 variant transitions

Study suggests SARS-CoV-2 vaccination in pregnancy induces diverging maternal and infant cord antibody functions

Europeans' life satisfaction recovers to pre-pandemic levels despite COVID-19 impact, study finds

Study examines the reinfection of SARS-CoV-2 variants in children

Monovalent mRNA COVID-19 vaccines provide durable protection against critical outcomes

New technology can deliver gene therapy directly to the lung

Cats and COVID-19: measuring seroprevalence against SARS-CoV-2 in domestic cats

Tracking SARS-CoV-2 Omicron variant XBB1.16

NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescent

Research uncovers antibodies that are still effective against new variants of SARS-CoV-2

The Wonder of DNA: Reflections from Dr. Francis Collins on the 20th Anniversary of the Human Genome Project

Study outlines protocols for safely shipping goods without starting SARS-CoV-2 outbreak

What are the trends in severe outcomes among patients hospitalized with COVID-19 during the first 2 years of the COVID-19 pandemic?

Deciphering immunological imprinting in the context of COVID-19

Novel self-amplifying RNA vaccine confers durable protection against COVID-19, reduces viral shedding in primate study

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News